One Patient's Search for the Right PsA Biologic

In "One Patient's Search for the Right PsA Biologic," Kameillia recounts the years of trial and error behind her current treatment.

Kameillia describes her treatment history before and after reaching Dr. Perkins. Early on, other providers offered NSAIDs, which did little for her pain, and then opioids, which she declined long term because of their addictive potential. Once under Dr. Perkins' care, she cycled through roughly eight medications across multiple drug classes. The first, an anti-inflammatory biologic, brought no real improvement and caused an injection-site reaction. Meloxicam and other agents helped with inflammation but produced no lasting results. Another biologic triggered rashes that lasted for months with little relief, so Dr. Perkins moved her to a different class entirely. A JAK inhibitor eased some symptoms but caused persistent bladder spasms that Dr. Perkins judged intolerable. Kameillia eventually reached an IL-17A inhibitor, ixekizumab, which she says brought roughly a 40% drop in her pain level and measurable improvement in her joints and ligaments, delivered as a single monthly injection. Dr. Perkins recalls the process from her side. She notes she tried several more drug classes beyond the ones Kameillia lists. Psoriatic arthritis patients often see one aspect of disease improve while another does not, such as clearer skin without joint relief, or the reverse. She checked outcomes every three to six months to see whether the medication was truly working. She adds that Kameillia's eventual biologic caused no allergic reaction, a genuine relief after a prior drug reaction. It also brought no notable side effects at all, which made it easier to stay on. Even so, Kameillia says flare-ups kept returning. Both she and Dr. Perkins kept asking what else could be done, especially as her weight steadily climbed throughout this long search for the right drug.

In "How Obesity Impacts Psoriatic Arthritis Treatment Response," the panel turns to how obesity itself was working against Kameillia's treatment all along.